LOINC Panel Details 94504-8 SARS-CoV-2 (COVID-19) Ab panel

94769-7 SARS-CoV-2 (COVID-19) Ab [Units/volume] in Serum or Plasma by Immunoassay

Term Description

Quantitative detection of any SARS-CoV-2 antibodies (IgG, IgM, or IgA) in serum or plasma by immunoassay methods.
Source: Regenstrief LOINC

Part Descriptions

LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Fully-Specified Name

Component: SARS coronavirus 2 Ab
Property: ACnc
Time: Pt
System: Ser/Plas
Scale: Qn
Method: IA

Additional Names

Short Name: SARS-CoV-2 Ab SerPl IA-aCnc
Display Name: SARS-CoV-2 (COVID-19) Ab IA Qn
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) antibody, Blood

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.68
Last Updated: Version 2.71
Change Reason: Release 2.71: DefinitionDescription: Corrected "qualitative" to "quantitative".;
Order vs. Observation: Both

Member of these Panels

LOINC	Long Common Name
94504-8	SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay

Member of these Groups Get Info

LOINC Group	Group Name
LG51018-6	SARSCoV2 antibody detection

Language Variants Get Info

Tag	Language	Translation
de-AT	German (Austria)	Synonyms: SARS-CoV-2-AK
de-DE	German (Germany)	SARS-Coronavirus 2 Ak:Arbiträre Konzentration:Zeitpunkt:Serum oder Plasma:Quantitativ:Immunoassay
es-ES	Spanish (Spain)	Panel del SARS-CoV-2 (COVID-19) Anticuerpos:Concentración arbitraria:Punto temporal:Suero o Plasma:Qn:IA Synonyms: Cuantitativo
es-MX	Spanish (Mexico)	Coronavirus 2 Ab del SARS:Concentración arbitraria:Punto temporal:Suero o Plasma:Cuantitativo:Inmunoensayo
fr-FR	French (France)	Coronavirus SARS-CoV-2 Ac:Arbitraire/Volume:Ponctuel:Sérum/Plasma:Numérique:Immunoanalyse
fr-CA	French (Canada)	coronavirus 2 du SRAS , Ac:Concentration arbitraire:Temps ponctuel:Sérum/Plasma:Quantitatif:IA
it-IT	Italian (Italy)	SARS coronavirus 2 Ab:ACnc:Pt:Siero/Plasma:Qn:IA Synonyms: anticorpo Concentrazione Arbitraria Coronavirus della SARS Immunoassay Microbiologia Plasma Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma
nl-NL	Dutch (Netherlands)	SARS-CoV-2 As:eenheid/volume:moment:serum of plasma:kwantitatief:immunoassay Synonyms: antistof; antilichaam IA SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL	Polish (Poland)	SARS-CoV-2 Ab:stężenie w jednostkach umownych:punkt w czasie:surowica lub osocze:ilościowy:metoda immunologiczna Synonyms: Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19)
zh-CN	Chinese (China)	SARS 冠状病毒 2 抗体:任意型浓度:时间点:血清/血浆:定量型:免疫测定法 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒任意型浓度(单位体积);任意浓度;单位体积的任意单位数;人工型浓度免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验可用数量表示的;定量性;数值型;数量型;连续数值型标尺微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）时刻;随机;随意;瞬间血清或血浆

Example Units

Unit	Source
[IU]/mL	Example UCUM Units

94762-2 SARS-CoV-2 (COVID-19) Ab [Presence] in Serum or Plasma by Immunoassay

Term Description

Qualitative detection of SARS-CoV-2 antibodies by an immunoassay method, such as an enzyme-linked immunosorbent assay or electrochemiluminescence immunoassay, in serum or plasma. This assay detects but does not differentiate between the antibody subtypes.
Source: Regenstrief LOINC

Part Descriptions

LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Fully-Specified Name

Component: SARS coronavirus 2 Ab
Property: PrThr
Time: Pt
System: Ser/Plas
Scale: Ord
Method: IA

Additional Names

Short Name: SARS-CoV-2 Ab SerPl Ql IA
Display Name: SARS-CoV-2 (COVID-19) Ab IA Ql
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) antibody, Blood

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.68
Last Updated: Version 2.69
Order vs. Observation: Both

Example Answer List LL4994-1

Answer	Code	Score	Answer ID
Nonreactive Copyright http://snomed.info/sct ID:131194007 Non-reactive (qualifier value)			LA15256-3
Reactive Copyright http://snomed.info/sct ID:11214006 Reactive (qualifier value)			LA15255-5

Member of these Panels

LOINC	Long Common Name
94504-8	SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay

Member of these Groups Get Info

LOINC Group	Group Name
LG51018-6	SARSCoV2 antibody detection

Language Variants Get Info

Tag	Language	Translation
de-AT	German (Austria)	Synonyms: SARS-CoV-2-AK ql.
de-DE	German (Germany)	SARS-Coronavirus 2 Ak:Nachweis oder Schwellenwert:Zeitpunkt:Serum oder Plasma:Ordinal:Immunoassay
es-ES	Spanish (Spain)	Panel del SARS-CoV-2 (COVID-19) Anticuerpos:PrThr:Punto temporal:Suero o Plasma:Ord:IA
es-MX	Spanish (Mexico)	Coronavirus 2 Ab del SARS:Presencia o umbral:Punto temporal:Suero o Plasma:Ordinal:Inmunoensayo
fr-FR	French (France)	Coronavirus SARS-CoV-2 Ac:Présence/Seuil:Ponctuel:Sérum/Plasma:Qualitatif:Immunoanalyse
fr-CA	French (Canada)	coronavirus 2 du SRAS , Ac:Présence-Seuil:Temps ponctuel:Sérum/Plasma:Ordinal:IA
it-IT	Italian (Italy)	SARS coronavirus 2 Ab:PrThr:Pt:Siero/Plasma:Ord:IA Synonyms: anticorpo Coronavirus della SARS Immunoassay Microbiologia Plasma Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma
nl-NL	Dutch (Netherlands)	SARS-CoV-2 As:aanwezigheid:moment:serum of plasma:ordinaal:immunoassay Synonyms: antistof; antilichaam IA SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL	Polish (Poland)	SARS-CoV-2 Ab:granica wykrywalności:punkt w czasie:surowica lub osocze:półilościowy:metoda immunologiczna Synonyms: Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19)
zh-CN	Chinese (China)	SARS 冠状病毒 2 抗体:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值）微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）时刻;随机;随意;瞬间血清或血浆

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

94720-0 SARS-CoV-2 (COVID-19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay

Term Description

Quantitative results for detection of IgA antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum or plasma by immunoassay methods. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Source: Regenstrief LOINC

Part Descriptions

LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Fully-Specified Name

Component: SARS coronavirus 2 Ab.IgA
Property: ACnc
Time: Pt
System: Ser/Plas
Scale: Qn
Method: IA

Additional Names

Short Name: SARS-CoV-2 IgA SerPl IA-aCnc
Display Name: SARS-CoV-2 (COVID-19) IgA IA Qn
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) IgA antibody, Blood

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.68
Last Updated: Version 2.69
Order vs. Observation: Both

Member of these Panels

LOINC	Long Common Name
94504-8	SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay

Member of these Groups Get Info

LOINC Group	Group Name
LG51018-6	SARSCoV2 antibody detection

Language Variants Get Info

Tag	Language	Translation
de-DE	German (Germany)	SARS-Coronavirus 2 Ak.IgA:Arbiträre Konzentration:Zeitpunkt:Serum oder Plasma:Quantitativ:Immunoassay
es-ES	Spanish (Spain)	Panel del SARS-CoV-2 (COVID-19) IgA:Concentración arbitraria:Punto temporal:Suero o Plasma:Qn:IA Synonyms: Cuantitativo
es-MX	Spanish (Mexico)	SARS coronavirus 2 Ab.IgA:Concentración arbitraria:Punto temporal:Suero o Plasma:Cuantitativo:Inmunoensayo
fr-CA	French (Canada)	coronavirus 2 du SRAS , IgA:Concentration arbitraire:Temps ponctuel:Sérum/Plasma:Quantitatif:IA
fr-FR	French (France)	Coronavirus SARS-CoV-2 Ac IgA:Arbitraire/Volume:Ponctuel:Sérum/Plasma:Numérique:Immunoanalyse
it-IT	Italian (Italy)	SARS coronavirus 2 Ab.IgA:ACnc:Pt:Siero/Plasma:Qn:IA Synonyms: anticorpi anti-IgA anticorpo Concentrazione Arbitraria Coronavirus della SARS Immunoassay Microbiologia Plasma Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma
nl-NL	Dutch (Netherlands)	SARS-CoV-2 As.IgA:eenheid/volume:moment:serum of plasma:kwantitatief:immunoassay Synonyms: antistof; antilichaam IA SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL	Polish (Poland)	SARS-CoV-2 Ab.IgA:stężenie w jednostkach umownych:punkt w czasie:surowica lub osocze:ilościowy:metoda immunologiczna Synonyms: Immunoglobulina A Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgA do SARS-CoV-2 (COVID-19) (COVID-19)
zh-CN	Chinese (China)	SARS 冠状病毒 2 抗体.IgA:任意型浓度:时间点:血清/血浆:定量型:免疫测定法 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab.IgA;IgA;抗体 IgA Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒任意型浓度(单位体积);任意浓度;单位体积的任意单位数;人工型浓度免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验免疫球蛋白 A 可用数量表示的;定量性;数值型;数量型;连续数值型标尺微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）时刻;随机;随意;瞬间血清或血浆

Example Units

Unit	Source
[IU]/mL	Example UCUM Units

94562-6 SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

Term Description

Detection of SARS-CoV-2 IgA antibodies by an immunoassay method, such as enzyme-linked immunosorbent assay. This test is used in conjunction with SARS-CoV-2 IgM and IgG to aid in the diagnosis of COVID-19 and in the identification of individuals infected with SARS-CoV-2.
Source: Regenstrief LOINC

Part Descriptions

LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Fully-Specified Name

Component: SARS coronavirus 2 Ab.IgA
Property: PrThr
Time: Pt
System: Ser/Plas
Scale: Ord
Method: IA

Additional Names

Short Name: SARS-CoV-2 IgA SerPl Ql IA
Display Name: SARS-CoV-2 (COVID-19) IgA IA Ql
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) IgA antibody, Blood

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.68
Last Updated: Version 2.69
Order vs. Observation: Both

Example Answer List LL2009-0

Answer	Code	Score	Answer ID
Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value)			LA6576-8
Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value)			LA6577-6
Equivocal Copyright http://snomed.info/sct ID:42425007 Equivocal (qualifier value)			LA11885-3

Member of these Panels

LOINC	Long Common Name
94504-8	SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay

Member of these Groups Get Info

LOINC Group	Group Name
LG51018-6	SARSCoV2 antibody detection

Language Variants Get Info

Tag	Language	Translation
de-AT	German (Austria)	Synonyms: SARS-CoV-2-AK IgA ql
de-DE	German (Germany)	SARS-Coronavirus 2 Ak.IgA:Nachweis oder Schwellenwert:Zeitpunkt:Serum oder Plasma:Ordinal:Immunoassay
es-ES	Spanish (Spain)	Panel del SARS-CoV-2 (COVID-19) IgA:PrThr:Punto temporal:Suero o Plasma:Ord:IA
es-MX	Spanish (Mexico)	SARS coronavirus 2 Ab.IgA:Presencia o umbral:Punto temporal:Suero o Plasma:Ordinal:Inmunoensayo
fr-FR	French (France)	Coronavirus SARS-CoV-2 Ac IgA:Présence/Seuil:Ponctuel:Sérum/Plasma:Qualitatif:Immunoanalyse
fr-CA	French (Canada)	coronavirus 2 du SRAS , IgA:Présence-Seuil:Temps ponctuel:Sérum/Plasma:Ordinal:IA
it-IT	Italian (Italy)	SARS coronavirus 2 Ab.IgA:PrThr:Pt:Siero/Plasma:Ord:IA Synonyms: anticorpi anti-IgA anticorpo Coronavirus della SARS Immunoassay Microbiologia Plasma Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma
nl-NL	Dutch (Netherlands)	SARS-CoV-2 As.IgA:aanwezigheid:moment:serum of plasma:ordinaal:immunoassay Synonyms: antistof; antilichaam IA SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL	Polish (Poland)	SARS-CoV-2 Ab.IgA:granica wykrywalności:punkt w czasie:surowica lub osocze:półilościowy:metoda immunologiczna Synonyms: Immunoglobulina A Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgA do SARS-CoV-2 (COVID-19) (COVID-19)
zh-CN	Chinese (China)	SARS 冠状病毒 2 抗体.IgA:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab.IgA;IgA;抗体 IgA Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验免疫球蛋白 A 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值）微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）时刻;随机;随意;瞬间血清或血浆

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

94506-3 SARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay

Term Description

Quantitative results for detection of IgM antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum or plasma by immunoassay methods. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Source: Regenstrief LOINC

Part Descriptions

LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Fully-Specified Name

Component: SARS coronavirus 2 Ab.IgM
Property: ACnc
Time: Pt
System: Ser/Plas
Scale: Qn
Method: IA

Additional Names

Short Name: SARS-CoV-2 IgM SerPl IA-aCnc
Display Name: SARS-CoV-2 (COVID-19) IgM IA Qn
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) IgM antibody, Blood

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.68
Last Updated: Version 2.69
Order vs. Observation: Both

Member of these Panels

LOINC	Long Common Name
94504-8	SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay

Member of these Groups Get Info

LOINC Group	Group Name
LG51018-6	SARSCoV2 antibody detection

Language Variants Get Info

Tag	Language	Translation
de-AT	German (Austria)	Synonyms: SARS-CoV-2-AK IgM
de-DE	German (Germany)	SARS-Coronavirus 2 Ak.IgM:Arbiträre Konzentration:Zeitpunkt:Serum oder Plasma:Quantitativ:Immunoassay
es-ES	Spanish (Spain)	Panel del SARS-CoV-2 (COVID-19) IgM:Concentración arbitraria:Punto temporal:Suero o Plasma:Qn:IA Synonyms: Cuantitativo
es-MX	Spanish (Mexico)	SARS coronavirus 2 Ab.IgM:Concentración arbitraria:Punto temporal:Suero o Plasma:Cuantitativo:Inmunoensayo
fr-FR	French (France)	Coronavirus SARS-CoV-2 Ac IgM:Arbitraire/Volume:Ponctuel:Sérum/Plasma:Numérique:Immunoanalyse
fr-CA	French (Canada)	coronavirus 2 du SRAS , IgM:Concentration arbitraire:Temps ponctuel:Sérum/Plasma:Quantitatif:IA
it-IT	Italian (Italy)	SARS coronavirus 2 Ab.IgM:ACnc:Pt:Siero/Plasma:Qn:IA Synonyms: Anticorpi IgM anticorpo Concentrazione Arbitraria Coronavirus della SARS Immunoassay Microbiologia Plasma Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma
nl-NL	Dutch (Netherlands)	SARS-CoV-2 As.IgM:eenheid/volume:moment:serum of plasma:kwantitatief:immunoassay Synonyms: antistof; antilichaam IA SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL	Polish (Poland)	SARS-CoV-2 Ab.IgM:stężenie w jednostkach umownych:punkt w czasie:surowica lub osocze:ilościowy:metoda immunologiczna Synonyms: IgM Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgM do SARS-CoV-2 (COVID-19)
zh-CN	Chinese (China)	SARS 冠状病毒 2 抗体.IgM:任意型浓度:时间点:血清/血浆:定量型:免疫测定法 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab.IgM;IgM;抗体 IgM Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒任意型浓度(单位体积);任意浓度;单位体积的任意单位数;人工型浓度免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验免疫球蛋白 M 可用数量表示的;定量性;数值型;数量型;连续数值型标尺微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）时刻;随机;随意;瞬间血清或血浆

Example Units

Unit	Source
[arb'U]/mL	Example UCUM Units

94564-2 SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum or Plasma by Immunoassay

Term Description

Detection of SARS-CoV-2 IgM antibodies by an immunoassay method, such as enzyme-linked immunosorbent assay. This test is used in conjunction with SARS-CoV-2 IgA and IgG to aid in the diagnosis of COVID-19 and in the identification of individuals infected with SARS-CoV-2.
Source: Regenstrief LOINC

Part Descriptions

LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Fully-Specified Name

Component: SARS coronavirus 2 Ab.IgM
Property: PrThr
Time: Pt
System: Ser/Plas
Scale: Ord
Method: IA

Additional Names

Short Name: SARS-CoV-2 IgM SerPl Ql IA
Display Name: SARS-CoV-2 (COVID-19) IgM IA Ql
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) IgM antibody, Blood

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.68
Last Updated: Version 2.69
Order vs. Observation: Both

Example Answer List LL2009-0

Answer	Code	Score	Answer ID
Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value)			LA6576-8
Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value)			LA6577-6
Equivocal Copyright http://snomed.info/sct ID:42425007 Equivocal (qualifier value)			LA11885-3

Member of these Panels

LOINC	Long Common Name
94504-8	SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay

Member of these Groups Get Info

LOINC Group	Group Name
LG51018-6	SARSCoV2 antibody detection

Language Variants Get Info

Tag	Language	Translation
de-DE	German (Germany)	SARS-Coronavirus 2 Ak.IgM:Nachweis oder Schwellenwert:Zeitpunkt:Serum oder Plasma:Ordinal:Immunoassay
es-ES	Spanish (Spain)	Panel del SARS-CoV-2 (COVID-19) IgM:PrThr:Punto temporal:Suero o Plasma:Ord:IA
es-MX	Spanish (Mexico)	SARS coronavirus 2 Ab.IgM:Presencia o umbral:Punto temporal:Suero o Plasma:Ordinal:Inmunoensayo
fr-FR	French (France)	Coronavirus SARS-CoV-2 Ac IgM:Présence/Seuil:Ponctuel:Sérum/Plasma:Qualitatif:Immunoanalyse
fr-CA	French (Canada)	coronavirus 2 du SRAS , IgM:Présence-Seuil:Temps ponctuel:Sérum/Plasma:Ordinal:IA
it-IT	Italian (Italy)	SARS coronavirus 2 Ab.IgM:PrThr:Pt:Siero/Plasma:Ord:IA Synonyms: Anticorpi IgM anticorpo Coronavirus della SARS Immunoassay Microbiologia Plasma Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma
nl-NL	Dutch (Netherlands)	SARS-CoV-2 As.IgM:aanwezigheid:moment:serum of plasma:ordinaal:immunoassay Synonyms: antistof; antilichaam IA SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL	Polish (Poland)	SARS-CoV-2 Ab.IgM:granica wykrywalności:punkt w czasie:surowica lub osocze:półilościowy:metoda immunologiczna Synonyms: IgM Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgM do SARS-CoV-2 (COVID-19)
zh-CN	Chinese (China)	SARS 冠状病毒 2 抗体.IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab.IgM;IgM;抗体 IgM Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验免疫球蛋白 M 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值）微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）时刻;随机;随意;瞬间血清或血浆

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

94505-5 SARS-CoV-2 (COVID-19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

Term Description

Quantitative results for detection of IgG antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum or plasma by immunoassay methods. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Source: Regenstrief LOINC

Part Descriptions

LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Fully-Specified Name

Component: SARS coronavirus 2 Ab.IgG
Property: ACnc
Time: Pt
System: Ser/Plas
Scale: Qn
Method: IA

Additional Names

Short Name: SARS-CoV-2 IgG SerPl IA-aCnc
Display Name: SARS-CoV-2 (COVID-19) IgG IA Qn
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) IgG antibody, Blood

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.68
Last Updated: Version 2.73
Order vs. Observation: Both
Common Test Rank Get Info: 789

Member of these Panels

LOINC	Long Common Name
94504-8	SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay

Member of these Groups Get Info

LOINC Group	Group Name
LG51018-6	SARSCoV2 antibody detection

Language Variants Get Info

Tag	Language	Translation
de-AT	German (Austria)	Synonyms: SARS-CoV-2-AK IgG
de-DE	German (Germany)	SARS-Coronavirus 2 Ak.IgG:Arbiträre Konzentration:Zeitpunkt:Serum oder Plasma:Quantitativ:Immunoassay
es-ES	Spanish (Spain)	Panel del SARS-CoV-2 (COVID-19) IgG:Concentración arbitraria:Punto temporal:Suero o Plasma:Qn:IA Synonyms: Cuantitativo
es-MX	Spanish (Mexico)	SARS coronavirus 2 Ab.IgG:Concentración arbitraria:Punto temporal:Suero o Plasma:Cuantitativo:Inmunoensayo
fr-FR	French (France)	Coronavirus SARS-CoV-2 Ac IgG:Arbitraire/Volume:Ponctuel:Sérum/Plasma:Numérique:Immunoanalyse
fr-CA	French (Canada)	coronavirus 2 du SRAS , IgG:Concentration arbitraire:Temps ponctuel:Sérum/Plasma:Quantitatif:IA
it-IT	Italian (Italy)	SARS coronavirus 2 Ab.IgG:ACnc:Pt:Siero/Plasma:Qn:IA Synonyms: anticorpi IgG anticorpo Concentrazione Arbitraria Coronavirus della SARS Immunoassay Microbiologia Plasma Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma
nl-NL	Dutch (Netherlands)	SARS-CoV-2 As.IgG:eenheid/volume:moment:serum of plasma:kwantitatief:immunoassay Synonyms: antistof; antilichaam IA SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL	Polish (Poland)	SARS-CoV-2 Ab.IgG:stężenie w jednostkach umownych:punkt w czasie:surowica lub osocze:ilościowy:metoda immunologiczna Synonyms: IgG Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgG do SARS-CoV-2 (COVID-19)
uk-UA	Ukrainian (Ukraine)	SARS коронавірус 2 Антитіла.IgG:Довільна Концентрація:МоментЧасу:Сироватка/Плазма:Кількісно:Імуноаналіз Synonyms: 2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SR; SUDS; Viral Pneumonias; Wuhan coronavirus
zh-CN	Chinese (China)	SARS 冠状病毒 2 抗体.IgG:任意型浓度:时间点:血清/血浆:定量型:免疫测定法 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab.IgG;IgG;抗体 IgG Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒任意型浓度(单位体积);任意浓度;单位体积的任意单位数;人工型浓度免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验免疫球蛋白 G 可用数量表示的;定量性;数值型;数量型;连续数值型标尺微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）时刻;随机;随意;瞬间血清或血浆

Example Units

Unit	Source
[arb'U]/mL	Example UCUM Units

96742-2 SARS-CoV-2 (COVID-19) IgG Ab [Mass/volume] in Serum or Plasma by Immunoassay

Term Description

Quantitative results for the detection of IgG antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum or plasma by immunoassay methods. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Source: Regenstrief LOINC

Part Descriptions

LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Fully-Specified Name

Component: SARS coronavirus 2 Ab.IgG
Property: MCnc
Time: Pt
System: Ser/Plas
Scale: Qn
Method: IA

Additional Names

Short Name: SARS-CoV-2 IgG SerPl IA-mCnc
Display Name: SARS-CoV-2 (COVID-19) IgG IA [Mass/Vol]
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) IgG antibody, Blood

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.70
Last Updated: Version 2.70
Order vs. Observation: Both

Member of these Panels

LOINC	Long Common Name
94504-8	SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay

Member of these Groups Get Info

LOINC Group	Group Name
LG51018-6	SARSCoV2 antibody detection

Language Variants Get Info

Tag	Language	Translation
de-DE	German (Germany)	SARS-Coronavirus 2 Ak.IgG:Massenkonzentration:Zeitpunkt:Serum oder Plasma:Quantitativ:Immunoassay
es-ES	Spanish (Spain)	Panel del SARS-CoV-2 (COVID-19) IgG:Concentración de masa:Punto temporal:Suero o Plasma:Qn:IA Synonyms: Cuantitativo
es-MX	Spanish (Mexico)	SARS coronavirus 2 Ab.IgG:MCnc:Punto temporal:Ser / Plas:Cuantitativo:I A
fr-CA	French (Canada)	coronavirus 2 du SRAS , IgG:Concentration de masse:Temps ponctuel:Sérum/Plasma:Quantitatif:IA
fr-FR	French (France)	Coronavirus SARS-CoV-2 Ac IgG:Masse/Volume:Ponctuel:Sérum/Plasma:Numérique:Immunoanalyse
it-IT	Italian (Italy)	SARS coronavirus 2 Ab.IgG:MCnc:Pt:Siero/Plasma:Qn:IA Synonyms: anticorpi IgG anticorpo Concentrazione di Massa Coronavirus della SARS Immunoassay Microbiologia Plasma Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma
nl-NL	Dutch (Netherlands)	SARS-CoV-2 As.IgG:massa/volume:moment:serum of plasma:kwantitatief:immunoassay Synonyms: antistof; antilichaam IA SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL	Polish (Poland)	SARS-CoV-2 Ab.IgG:stężenie masowe:punkt w czasie:surowica lub osocze:ilościowy:metoda immunologiczna Synonyms: IgG Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgG do SARS-CoV-2 (COVID-19)
zh-CN	Chinese (China)	SARS 冠状病毒 2 抗体.IgG:质量浓度:时间点:血清/血浆:定量型:免疫测定法 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab.IgG;IgG;抗体 IgG Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验免疫球蛋白 G 可用数量表示的;定量性;数值型;数量型;连续数值型标尺微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）时刻;随机;随意;瞬间水平;浓度;质量浓度(单位体积) 血清或血浆

Example Units

Unit	Source
ug/mL	Example UCUM Units

94563-4 SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

Term Description

Detection of SARS-CoV-2 IgG antibodies by an immunoassay method, such as enzyme-linked immunosorbent assay. This test is used in conjunction with SARS-CoV-2 IgA and IgM to aid in the diagnosis of COVID-19 and in the identification of individuals infected with SARS-CoV-2.
Source: Regenstrief LOINC

Part Descriptions

LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Fully-Specified Name

Component: SARS coronavirus 2 Ab.IgG
Property: PrThr
Time: Pt
System: Ser/Plas
Scale: Ord
Method: IA

Additional Names

Short Name: SARS-CoV-2 IgG SerPl Ql IA
Display Name: SARS-CoV-2 (COVID-19) IgG IA Ql
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) IgG antibody, Blood

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.68
Last Updated: Version 2.73
Order vs. Observation: Both
Common Test Rank Get Info: 5960

Example Answer List LL2009-0

Answer	Code	Score	Answer ID
Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value)			LA6576-8
Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value)			LA6577-6
Equivocal Copyright http://snomed.info/sct ID:42425007 Equivocal (qualifier value)			LA11885-3

Member of these Panels

LOINC	Long Common Name
94504-8	SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay

Member of these Groups Get Info

LOINC Group	Group Name
LG51018-6	SARSCoV2 antibody detection

Language Variants Get Info

Tag	Language	Translation
de-AT	German (Austria)	Synonyms: SARS-CoV-2-AK IgG ql.
de-DE	German (Germany)	SARS-Coronavirus 2 Ak.IgG:Nachweis oder Schwellenwert:Zeitpunkt:Serum oder Plasma:Ordinal:Immunoassay
es-ES	Spanish (Spain)	Panel del SARS-CoV-2 (COVID-19) IgG:PrThr:Punto temporal:Suero o Plasma:Ord:IA
es-MX	Spanish (Mexico)	SARS coronavirus 2 Ab.IgG:Presencia o umbral:Punto temporal:Suero o Plasma:Ordinal:Inmunoensayo
fr-FR	French (France)	Coronavirus SARS-CoV-2 Ac IgG:Présence/Seuil:Ponctuel:Sérum/Plasma:Qualitatif:Immunoanalyse
fr-CA	French (Canada)	coronavirus 2 du SRAS , IgG:Présence-Seuil:Temps ponctuel:Sérum/Plasma:Ordinal:IA
it-IT	Italian (Italy)	SARS coronavirus 2 Ab.IgG:PrThr:Pt:Siero/Plasma:Ord:IA Synonyms: anticorpi IgG anticorpo Coronavirus della SARS Immunoassay Microbiologia Plasma Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma
nl-NL	Dutch (Netherlands)	SARS-CoV-2 As.IgG:aanwezigheid:moment:serum of plasma:ordinaal:immunoassay Synonyms: antistof; antilichaam IA SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL	Polish (Poland)	SARS-CoV-2 Ab.IgG:granica wykrywalności:punkt w czasie:surowica lub osocze:półilościowy:metoda immunologiczna Synonyms: IgG Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgG do SARS-CoV-2 (COVID-19)
uk-UA	Ukrainian (Ukraine)	SARS коронавірус 2 Антитіла.IgG:Наявність або Поріг:МоментЧасу:Сироватка/Плазма:Порядково:Імуноаналіз Synonyms: 2019 Novel Coronavirus; 2019-nCoV; ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Corona virus; COVID19; COVID-19; EIA; ELFA; ELISA; Enzyme immunoassay; IAA; ID; II; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; MEIA; Microbiology; Ordinal; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; SARS Coronavirus 1; SARS-CoV; SARS-CoV-1; SARS-CoV-2; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; Severe Acute Respiratory Syndrome; SR; SUDS; Viral Pneumonias; Wuhan coronavirus
zh-CN	Chinese (China)	SARS 冠状病毒 2 抗体.IgG:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab.IgG;IgG;抗体 IgG Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验免疫球蛋白 G 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值）微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）时刻;随机;随意;瞬间血清或血浆

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

94547-7 SARS-CoV-2 (COVID-19) IgG+IgM Ab [Presence] in Serum or Plasma by Immunoassay

Term Description

Qualitative results for the detection of IgG and/or IgM antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), by immunoassay methods. The assay does not distinguish between IgG and IgM Ab so cannot differentiate between a recent and past infection. Testing is performed for the diagnosis of Coronavirus Disease 2019 (COVID-19).
Source: Regenstrief LOINC

Part Descriptions

LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Fully-Specified Name

Component: SARS coronavirus 2 Ab.IgG+IgM
Property: PrThr
Time: Pt
System: Ser/Plas
Scale: Ord
Method: IA

Additional Names

Short Name: SARS-CoV-2 IgG+IgM SerPl Ql IA
Display Name: SARS-CoV-2 (COVID-19) IgG+IgM IA Ql
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) IgG+IgM, Blood

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.68
Last Updated: Version 2.69
Order vs. Observation: Both

Example Answer List LL2009-0

Answer	Code	Score	Answer ID
Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value)			LA6576-8
Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value)			LA6577-6
Equivocal Copyright http://snomed.info/sct ID:42425007 Equivocal (qualifier value)			LA11885-3

Member of these Panels

LOINC	Long Common Name
94504-8	SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay

Member of these Groups Get Info

LOINC Group	Group Name
LG51018-6	SARSCoV2 antibody detection

Language Variants Get Info

Tag	Language	Translation
de-AT	German (Austria)	Synonyms: SARS-CoV-2-AK IgG+M
de-DE	German (Germany)	SARS-Coronavirus 2 Ak.IgG+IgM:Nachweis oder Schwellenwert:Zeitpunkt:Serum oder Plasma:Ordinal:Immunoassay
es-ES	Spanish (Spain)	Panel del SARS-CoV-2 (COVID-19) IgG+IgM:PrThr:Punto temporal:Suero o Plasma:Ord:IA
es-MX	Spanish (Mexico)	SARS coronavirus 2 Ab.IgG + IgM:Presencia o umbral:Punto temporal:Suero o Plasma:Ordinal:Inmunoensayo
fr-FR	French (France)	Coronavirus SARS-CoV-2 Ac IgG+IgM:Présence/Seuil:Ponctuel:Sérum/Plasma:Qualitatif:Immunoanalyse
fr-CA	French (Canada)	coronavirus 2 du SRAS , IgG+IgM:Présence-Seuil:Temps ponctuel:Sérum/Plasma:Ordinal:IA
it-IT	Italian (Italy)	SARS coronavirus 2 Ab.IgG+IgM:PrThr:Pt:Siero/Plasma:Ord:IA Synonyms: anticorpi IgG anticorpi IgG e IgM Anticorpi IgG+IgM anticorpo Coronavirus della SARS Immunoassay Microbiologia Plasma Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma
nl-NL	Dutch (Netherlands)	SARS-CoV-2 As.IgG + IgM:aanwezigheid:moment:serum of plasma:ordinaal:immunoassay Synonyms: antistof; antilichaam IA SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL	Polish (Poland)	SARS-CoV-2 Ab.IgG+IgM:granica wykrywalności:punkt w czasie:surowica lub osocze:półilościowy:metoda immunologiczna Synonyms: IgG IgM Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgG do SARS-CoV-2 (COVID-19) Przeciwciała IgG i IgM do SARS-CoV-2 (COVID-19)
zh-CN	Chinese (China)	SARS 冠状病毒 2 抗体.IgG+IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab.IgG;IgG;抗体 IgG Ab.IgG+IgM;IgG+IgM;抗体 IgG+抗体 IgM Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验免疫球蛋白 G 免疫球蛋白 M 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值）微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）抗体.IgG & IgM;抗体.IgG+IgM 时刻;随机;随意;瞬间血清或血浆

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

95125-1 SARS-CoV-2 (COVID-19) IgA+IgM [Presence] in Serum or Plasma by Immunoassay

Term Description

Qualitative detection of IgA and IgM antibodies against SARS coronavirus 2 (SARS-CoV-2), also known as the 2019 Novel Coronavirus (2019-nCoV), in serum or plasma by immunoassay methods. The assay does not distinguish between IgA and IgM.
Source: Regenstrief LOINC

Part Descriptions

LP417540-4 SARS coronavirus 2
The 2019 Novel Coronavirus (2019-nCoV) is a coronavirus first identified as the cause of a respiratory illness outbreak in Wuhan, China. Initially, the outbreak was linked to a large seafood and animal market and thought to only be spread by animal to person contact. Within a short time, a growing number of patients who had not been exposed to animal markets were diagnosed with the infection, indicating person-to-person transmission. As of January 2020, infections with 2019-nCoV had been reported internationally due to confirmed cases in travelers from Wuhan. Overall, clinical symptoms appear milder than SARS Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome (MERS) Coronavirus (MERS-CoV) infections as do the fatality rate and transmissibility. PMID: 31953166 Reported illnesses range from minor or no respiratory symptoms to severe acute respiratory illness and death.

The full genome of the 2019-nCoV was first posted by Chinese health authorities in GenBank, the NIH genetic sequence database, and in the Global Initiative on Sharing All Influenza Data (GISAI) portal. This facilitated detection of the virus globally with subsequent sequences being nearly identical, suggesting a single, recent emergence from a virus related to bat coronaviruses and the SARS coronavirus. Source: LOINC

Reference Information

Type	Source	Reference
Webcontent	Lab Tests Online^®Copyright Copyright © 2021 Lab Tests Online. All rights reserved.	Coronavirus (COVID-19) Testing

Fully-Specified Name

Component: SARS coronavirus 2 Ab.IgA+IgM
Property: PrThr
Time: Pt
System: Ser/Plas
Scale: Ord
Method: IA

Additional Names

Short Name: SARS-CoV-2 IgA+IgM SerPl Ql IA
Display Name: SARS-CoV-2 (COVID-19) IgA+IgM IA Ql
Consumer Name Alpha Get Info: SARS-CoV-2 (COVID-19) IgA+IgM, Blood

Basic Attributes

Class: MICRO
Type: Laboratory
First Released: Version 2.68
Last Updated: Version 2.69
Order vs. Observation: Both

Example Answer List LL2009-0

Answer	Code	Score	Answer ID
Positive Copyright http://snomed.info/sct ID:10828004 Positive (qualifier value)			LA6576-8
Negative Copyright http://snomed.info/sct ID:260385009 Negative (qualifier value)			LA6577-6
Equivocal Copyright http://snomed.info/sct ID:42425007 Equivocal (qualifier value)			LA11885-3

Member of these Panels

LOINC	Long Common Name
94504-8	SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay

Member of these Groups Get Info

LOINC Group	Group Name
LG51018-6	SARSCoV2 antibody detection

Language Variants Get Info

Tag	Language	Translation
de-DE	German (Germany)	SARS-Coronavirus 2 Ak.IgA+IgM:Nachweis oder Schwellenwert:Zeitpunkt:Serum oder Plasma:Ordinal:Immunoassay
es-ES	Spanish (Spain)	Panel del SARS-CoV-2 (COVID-19) Anticuerpor IgA + IgM:PrThr:Punto temporal:Suero o Plasma:Ord:IA
es-MX	Spanish (Mexico)	SARS coronavirus 2 Ab.IgA + IgM:Presencia o umbral:Punto temporal:Suero o Plasma:Ordinal:Inmunoensayo
fr-FR	French (France)	Coronavirus SARS-CoV-2 Ac IgA+IgM:Présence/Seuil:Ponctuel:Sérum/Plasma:Qualitatif:Immunoanalyse
it-IT	Italian (Italy)	SARS coronavirus 2 Ab.IgA+IgM:PrThr:Pt:Siero/Plasma:Ord:IA Synonyms: anticorpi anti-IgA anticorpo Coronavirus della SARS Immunoassay Microbiologia Plasma Presenza o Soglia Punto nel tempo (episodio) SARS-CoV-2 (COVID-19) Siero Siero o Plasma
nl-NL	Dutch (Netherlands)	SARS-CoV-2 As.IgA + IgM:aanwezigheid:moment:serum of plasma:ordinaal:immunoassay Synonyms: antistof; antilichaam IA SARS-virus severe acute respiratory syndrome coronavirus 2; 2019-nCoV; 2019 novel coronavirus; COVID-19
pl-PL	Polish (Poland)	SARS-CoV-2 Ab.IgA+IgM:granica wykrywalności:punkt w czasie:surowica lub osocze:półilościowy:metoda immunologiczna Synonyms: IgM Immunoglobulina A Koronawirus Przeciwciała do wirusa SARS-CoV-2 (COVID-19) Przeciwciała IgA do SARS-CoV-2 (COVID-19) (COVID-19) Przeciwciała IgA i IgM do SARS-CoV-2 (COVID-19)
zh-CN	Chinese (China)	SARS 冠状病毒 2 抗体.IgA+IgM:存在情况或阈值:时间点:血清/血浆:序数型:免疫测定法 Synonyms: 2019 新型冠状病毒;2019 年新型冠状病毒;2019-nCoV;SARS-CoV-2;新型冠状病毒肺炎;新冠肺炎;Coronavirus disease 2019;COVID-19;冠状病毒疾病2019;严重急性呼吸综合征;severe acute respiratory syndrome;SARS;传染性非典型肺炎;infectious atypical pneumonia;非典 Ⅱ Ab.IgA;IgA;抗体 IgA Ab;自身抗体 II SARS;SARS 病毒;SARS-CoV;严重急性呼吸综合征;严重急性呼吸综合征病毒;萨斯病毒;非典;非典型肺炎;非典型肺炎病毒;非典病毒依次型;分类顺序型;定性的;序数型（或称等级型）;性质上的;有序型;有序性分类应答;有序性分类结果;秩次型;等级型;筛查;顺序型免疫测定;免疫分析法;免疫检定法;免疫检定;免疫试验;酶免疫测定法;酶免疫测定;酶免疫分析法;酶免疫检定法;酶免疫检定;酶免疫试验免疫球蛋白 A 免疫球蛋白 M 存在情况;存在;存在与否;是否存在;阈值;界值;界限;阀值;临界值;存在情况（存在、存在与否、是否存在）或阈值（界值、界限、阀值、临界值）微生物学;微生物学试验;微生物学试验（培养、DNA、抗原及抗体）抗体（Ab）.IgA+IgM 时刻;随机;随意;瞬间血清或血浆

Third Party Copyright

This material includes SNOMED Clinical Terms® (SNOMED CT®) which is used by permission of the International Health Terminology Standards Development Organisation (IHTSDO) under license. All rights reserved. SNOMED CT® was originally created by The College of American Pathologists. "SNOMED" and "SNOMED CT" are registered trademarks of the IHTSDO.

This material includes content from the US Edition to SNOMED CT, which is developed and maintained by the U.S. National Library of Medicine and is available to authorized UMLS Metathesaurus Licensees from the UTS Downloads site at https://uts.nlm.nih.gov.

Use of SNOMED CT content is subject to the terms and conditions set forth in the SNOMED CT Affiliate License Agreement. It is the responsibility of those implementing this product to ensure they are appropriately licensed and for more information on the license, including how to register as an Affiliate Licensee, please refer to http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org<mailto:info@snomed.org>. This may incur a fee in SNOMED International non-Member countries.

94504-8

SARS-CoV-2 (COVID-19) Ab panel - Serum or Plasma by Immunoassay

Active

94769-7 SARS-CoV-2 (COVID-19) Ab [Units/volume] in Serum or Plasma by Immunoassay

Term Description

Part Descriptions

Reference Information

Fully-Specified Name

Additional Names

Basic Attributes

Member of these Panels

Member of these Groups Get Info

Language Variants Get Info

Related Names

Example Units

94762-2 SARS-CoV-2 (COVID-19) Ab [Presence] in Serum or Plasma by Immunoassay

Term Description

Part Descriptions

Reference Information

Fully-Specified Name

Additional Names

Basic Attributes

Example Answer List LL4994-1

Member of these Panels

Member of these Groups Get Info

Language Variants Get Info

Related Names

Third Party Copyright

94720-0 SARS-CoV-2 (COVID-19) IgA Ab [Units/volume] in Serum or Plasma by Immunoassay

Term Description

Part Descriptions

Reference Information

Fully-Specified Name

Additional Names

Basic Attributes

Member of these Panels

Member of these Groups Get Info

Language Variants Get Info

Related Names

Example Units

94562-6 SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

Term Description

Part Descriptions

Reference Information

Fully-Specified Name

Additional Names

Basic Attributes

Example Answer List LL2009-0

Member of these Panels

Member of these Groups Get Info

Language Variants Get Info

Related Names

Third Party Copyright

94506-3 SARS-CoV-2 (COVID-19) IgM Ab [Units/volume] in Serum or Plasma by Immunoassay

Term Description

Part Descriptions

Reference Information

Fully-Specified Name

Additional Names

Basic Attributes

Member of these Panels

Member of these Groups Get Info

Language Variants Get Info

Related Names

Example Units

94564-2 SARS-CoV-2 (COVID-19) IgM Ab [Presence] in Serum or Plasma by Immunoassay

Term Description

Part Descriptions

Reference Information

Fully-Specified Name

Additional Names

Basic Attributes

Example Answer List LL2009-0

Member of these Panels

Member of these Groups Get Info

Language Variants Get Info

Related Names

Third Party Copyright

94505-5 SARS-CoV-2 (COVID-19) IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

Term Description